KL1333, orphan drug approved for the treatment of mitochondrial disorders

[Ema]

“KL1333 is a potent regulator of the cellular levels of NAD+, a key molecule in the cell’s energy metabolism. In preclinical studies, KL1333 was able to increase mitochondrial energy levels, reduce the formation and accumulation of toxic compounds (e.g., lactate and free radicals), and induce the formation of new mitochondria.”

https://mitochondrialdiseasenews.co...rphan-drug-status-mitochondrial-diseases/?amp

 

[nanonug]

“KL1333 is a potent regulator of the cellular levels of NAD+

Awesome! Looking forward to put my hands on this when available.

 

[HowToEscape?]

Awesome! Looking forward to put my hands on this when available.

A pre-clinical study is a long way from proof that this stuff is effective for the treatment of any disease, much less one one understands. Hope it pans out, don’t hold your breath.